Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
$ in Thousands
Cumulative Effect, Period of Adoption, Adjustment
Legacy Convertible Preferred Stock
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Cumulative Effect, Period of Adoption, Adjustment
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjustment
Cumulative Effect, Period of Adoption, Adjusted Balance
Common Stock
Cumulative Effect, Period of Adoption, Adjusted Balance
Additional Paid-In Capital
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjusted Balance
Accumulated Other Comprehensive (Loss) Income
Cumulative Effect, Period of Adoption, Adjusted Balance
Legacy Convertible Preferred Stock
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive (Loss) Income
Total
BALANCE at Dec. 31, 2019 $ (436,533)                 $ 436,533          
BALANCE (in shares) at Dec. 31, 2019 (100,038,109)                 100,038,109          
BALANCE at Dec. 31, 2019   $ 13 $ 436,520 $ 436,533 $ 16 $ 453,242 $ (294,262) $ 75 $ 159,071   $ 3 $ 16,722 $ (294,262) $ 75 $ (277,462)
BALANCE (in shares) at Dec. 31, 2019   128,100,821     154,913,934           26,813,113        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Exercise of Common Stock options                       132     132
Exercise of Common Stock options (in shares)                     286,636        
Vesting of restricted Common Stock                       2     2
Vesting of restricted Common Stock (in shares)                     1,750,555        
Stock-based compensation expense                       1,259     1,259
Common Stock warrants issued                       124     124
Net loss                         (21,804)   (21,804)
Other comprehensive income (loss)                           (159) (159)
BALANCE at Mar. 31, 2020                     $ 16 454,759 (316,066) (84) 138,625
BALANCE (in shares) at Mar. 31, 2020                     156,951,125        
BALANCE at Dec. 31, 2020                     $ 23 844,188 (328,277) (9) 515,925
BALANCE (in shares) at Dec. 31, 2020                     224,626,597        
Increase (Decrease) in Stockholders' Equity [Roll Forward]                              
Exercise of Common Stock options                       180     180
Exercise of Common Stock options (in shares)                     163,228        
Vesting of restricted Common Stock (in shares)                     56,015        
Vesting of restricted stock units (in shares)                     15,265        
Repurchase of shares for employee tax withholdings                       (54)     (54)
Repurchase of shares for employee tax withholdings (in shares)                     (2,241)        
Issuance of Common Stock for acquisitions                       159,847     159,847
Issuance of Common Stock for acquisitions (in shares)                     5,036,142        
Stock-based compensation expense                       2,217     2,217
Vesting of Trine Founder shares (in shares)                     1,850,938        
Exercise of warrants                     $ 2 320,567     320,569
Exercise of warrants (in shares)                     20,690,975        
Net loss                         (59,108)   (59,108)
Other comprehensive income (loss)                           (12) (12)
BALANCE at Mar. 31, 2021                     $ 25 $ 1,326,945 $ (387,385) $ (21) $ 939,564
BALANCE (in shares) at Mar. 31, 2021                     252,436,919